Early research (Phase 1)Ended earlyNCT04239092
What this trial is testing
9-ING-41 in Pediatric Patients With Refractory Malignancies.
Who this might be right for
Refractory CancerRefractory NeoplasmCancer Pediatric+8 more
Actuate Therapeutics Inc. 40